<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668614</url>
  </required_header>
  <id_info>
    <org_study_id>HSREB 107218</org_study_id>
    <nct_id>NCT02668614</nct_id>
  </id_info>
  <brief_title>Early Detection of Skin Cancer With Sensor Technology</brief_title>
  <official_title>Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Skin cancer represents a large problem in today's healthcare setting. The majority of cancer&#xD;
      diagnoses are attributed to malignant skin diseases including its major types: basal cell&#xD;
      carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early&#xD;
      detection of malignant lesions largely increases chances of successful treatment. The current&#xD;
      gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are&#xD;
      not only invasive and expensive, they have variable positive predictive value, meaning they&#xD;
      may often be preformed unnecessarily. As such, the investigators have developed a skin&#xD;
      scanner, which is less bulky and expensive than existing similar technologies, as a tool to&#xD;
      evaluate skin lesions prior to determining the need for a biopsy. Their objective is to&#xD;
      obtain information in order to validate this skin scanner in the context of its ability to&#xD;
      accurately identify basal cell carcinoma skin lesions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive predictive value</measure>
    <time_frame>Immediately pre-biopsy</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Carcinoma, Basal Cell</condition>
  <arm_group>
    <arm_group_label>WR-22 model microwave sensor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WR-22 model microwave sensor</intervention_name>
    <arm_group_label>WR-22 model microwave sensor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Poor english fluency, Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>November 2, 2018</last_update_submitted>
  <last_update_submitted_qc>November 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Detection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

